To assess the Brightening Potential of The Derma Co 15percent Vitamin C Intense Brightening Ampoule Kit

A Clinical Study to Evaluate the Brightening Potential of The Derma Co 15 percent Vitamin C Intense Brightening Ampoule Kit on Healthy Human Subjects - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/07/071534

Enrollment

Registered

2024-07-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product-The Derma Co 15% Vitamin C Intense Brightening Ampoule Kit: Dose: Apply whole ampule drop wise in outward direction. Duration- once (1 day), Route of administration- Topica

Eligibility

Inclusion criteria

Inclusion criteria: 1.Gender: Male or Female with age 18-45, with male:female (80:20) ratio with normal , oily (avoid acne and too much oily skin) and combination skin. 3 to 4 candidates with Sensitive skin. 2. Subjects willing to give written informed consent 3. Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4. Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study. 6. Should be able to read and write (in English, Hindi or local language). 7. Having valid proof of identity and age.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing mothers 2.Scars, excessive terminal hair or tattoo on the studied area 3.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 4.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 5.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 6.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Design outcomes

Primary

Measure	Time frame
1. Change in Lightness 2. Change in melanin 3. Gloss by glossymeterTimepoint: At 0, 30 min, 7days	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results